World Diabetes Foundation, Gentofte, Denmark.
Divakar's Specialty Hospital, Bangalore, India.
Diabetes Res Clin Pract. 2018 Nov;145:88-92. doi: 10.1016/j.diabres.2018.01.025. Epub 2018 Feb 2.
Estimates indicate that south Asia accounts for over two fifths of the global burden of hyperglycemia in pregnancy (HIP) and the ongoing nutritional and epidemiological transition may make the situation worse. Given their higher risk, all women of south Asian decent require to be tested for HIP. With approximately 37 million births annually in the region requires that 37 million women be tested annually; thereby placing a huge burden on the fragile inadequately resourced health systems in the region with poor awareness and lack of trained manpower. Recommendation for testing must therefore be pragmatic, feasible, convenient and cost effective. Diabetes in pregnancy study group India (DIPSI) has proposed a simple testing protocol that is endorsed by the Indian National Guideline on GDM, and by the FIGO guideline on HIP for use in South Asia. This testing protocol has received widespread support in the region. Despite the many challenges it is encouraging to note that in the four large countries in the region - Bangladesh, India, Pakistan and Sri Lanka which account for over 80% of the estimated burden of HIP in south Asia, large scale credible programs have been initiated to address the identified barriers.
估计表明，南亚地区占全球妊娠高血糖（HIP）负担的五分之二以上，而持续的营养和流行病学转变可能使情况恶化。鉴于南亚裔女性的风险更高，所有南亚裔女性都需要接受 HIP 检测。该地区每年约有 3700 万例分娩，这意味着每年需要对 3700 万名女性进行检测；因此，这给该地区脆弱、资源不足的卫生系统带来了巨大负担，该地区意识薄弱，缺乏训练有素的人力。因此，检测建议必须务实、可行、方便且具有成本效益。印度妊娠糖尿病研究组（DIPSI）提出了一项简单的检测方案，该方案得到了印度国家 GDM 指南和FIGO HIP 指南的认可，可在南亚地区使用。该检测方案在该地区得到了广泛支持。尽管面临许多挑战，但值得欣慰的是，在该地区四个大国 - 孟加拉国、印度、巴基斯坦和斯里兰卡，它们占南亚 HIP 估计负担的 80%以上，已经启动了大规模的可靠计划来解决已确定的障碍。
